RedDress announced the launch of ActiGraft as the first wound care treatment that enables healthcare providers to produce – in real time – a patient’s blood into an autologous whole blood clot tissue to heal wounds and ulcers.
The Food and Drug Administration (FDA) informed that Granulex Aerosol Spray (trypsin, balsam peru, castor oil; Mylan) has been discontinued due to market conditions.
Hospital-Acquired Conditions Initiative cut payment in 0.003 percent of discharges
Telemedicine monitoring is not associated with any significant difference in amputation or healing, but may be linked to increased mortality for patients with diabetic foot ulcers.
A new “smart bandage” has been developed that can detect early tissue damage from pressure ulcers before they are visible to the human eye.
Two clinical practice guidelines provide recommendations on prevention, treatment
Eight weeks of formula enriched with arginine, zinc, and antioxidants linked to improved healing
BioMonde announced the launch of BioBag, a biosurgical medical device for wound debridement.
Hospital-acquired conditions (HACs) experienced a 17% decline from 2010-2013 and a 9% reduction from 2012-2013, according to figures released by the Centers for Medicare & Medicaid Services (CMS) and the U.S. Department of Health and Human Services (HHS).
Patient-specific orthoses manufactured on the basis of foot shape and barefoot plantar pressure are better compared to those manufactured only on the basis of foot shape and clinical insight.
